Modelling the effects of integrating diabetic retinopathy services in the Malawi health system

ISRCTN ISRCTN10051344
DOI https://doi.org/10.1186/ISRCTN10051344
Submission date
27/03/2025
Registration date
08/04/2025
Last edited
06/06/2025
Recruitment status
Recruiting
Overall study status
Ongoing
Condition category
Eye Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
Diabetes is a growing problem in Africa, with 24 million adults currently affected and this number expected to rise to 55 million by 2045. One of the most common complications of diabetes is diabetic retinopathy (DR), which can lead to blindness. In Malawi, 500,000 people with diabetes need regular eye screenings to prevent sight loss. This study aims to reduce sight loss from diabetes in Malawi by developing models to integrate DR screening and treatment into the health system. These models will help health policymakers decide which interventions to prioritize.

Who can participate?
Adults aged 18 and over, policy stakeholders involved in non-communicable diseases (NCDs) and DR, and patients with diabetes who are attending DR screening.

What does the study involve? (for participants)
Participants will be involved in various activities, including providing information through cross-sectional studies to understand the magnitude and risk factors for DR, participating in interviews and document reviews for policy coherence analysis, and engaging with the research team to help develop and refine the models for DR service delivery.

What are the possible benefits and risks of participating?
The benefits include contributing to research that aims to improve DR services and prevent blindness in Malawi, and helping to shape health policies that could benefit many people with diabetes. The risks are minimal, mainly related to the time and effort required to participate in the study activities.

Where is the study run from?
The study is run from Malawi, with key partnerships including the International Centre for Eye Health (ICEH) at the London School of Hygiene and Tropical Medicine, the Malawi Ministry of Health, and Kamuzu University of Health Sciences (KUHeS).

When is the study starting and how long is it expected to run for?
October 2024 to September 2027

Who is funding the study?
NIHR Global Health Policy and Systems Research Programme (UK)

Who is the main contact?
Dr Covadonga Bascaran (covadonga.bascaran@lshtm.ac.uk)

Contact information

Dr Covadonga Bascaran
Public, Scientific, Principal Investigator

LSHTM Keppel Street
London
WC1E 7HT
United Kingdom

ORCiD logoORCID ID 0000-0002-5662-3325
Phone +44 (0)20 7436 5389
Email covadonga.bascaran@lshtm.ac.uk

Study information

Study designObservational mixed methods
Primary study designObservational
Secondary study designEpidemiological study
Study setting(s)Hospital, Medical and other records, Other
Study typeTreatment
Scientific titleModelling the health system to assess the health gains of diabetic retinopathy service delivery models in Malawi
Study acronymMEDREM
Study objectivesModelling the health system can help inform policy makers on the health values attached to integrating DR services in health delivery
Ethics approval(s)

Not yet submitted 27/02/2025, London School of Hygiente & Tropical Medicne (Keppel Street, London, WC1E 7HT, United Kingdom)

Health condition(s) or problem(s) studiedDiabetic retinopathy
Intervention1. Secondary data analysis
• Scoping review of the models used to deliver DR services in LMICs
• Cross-sectional study that will be performed through secondary data analysis of hospital based-data and population-based data
-Population-based records of patients recruited in a previous survey (WP2), where some were diagnosed with DM (n = 45) and some had pre-diabetes (n=275)
-Hospital records of patients with DM who underwent DR screening between April 2023 and December 2024 (n = 720)
-Hospital records of patients with DM who underwent DR screening between August 2021 to August 2022 and underwent follow-up DR screening at any point one year after the initial screening (n =129)

2. Primary data collection
• Health policy analysis on service delivery for DM and DR in Malawi
-Participants: DR policy actors i.e. representatives of stakeholder who influence or are affected by policies relevant to DR in Malawi : n ≥ 16 ; Semi structured interviews.
• Health systems assessment of DR services in Malawi
-DR stakeholder representatives in the health system in Malawi : n ≥ 16 ; Semistructured interviews
• Cross-sectional study on the eye health-seeking behaviour of PLWD in Malawi (WP5)
-Participants: Patients accessing primary, secondary and tertiary-level DM care from 16 health facilities across 12 districts in Malawi: n = 411; Structured Questionnaires

3. An economic modelling study
• Of the health system for diabetes and DR to compare the cost-effectiveness and health gains of different DR service delivery models in Malawi
Intervention typeOther
Primary outcome measure1. Proportion of PLWD that have DR measured using patient records
2. Proportion of PLWD who develop DR over a 4 year period measured using patient records
3. Proportion of PLWD who have had a retinal examination measured using patient records
4. QALYs gained, resulting from DR screening and treatment interventions measured using patient records
Secondary outcome measuresThere are no secondary outcome measures
Overall study start date01/10/2024
Completion date30/09/2027

Eligibility

Participant type(s)Patient, Employee
Age groupAdult
Lower age limit18 Years
Upper age limit100 Years
SexBoth
Target number of participants745 adults; 715 people with diabetes; 9 stakeholders
Key inclusion criteria1. Adults ≥18 years old
2. Policy stakeholders in NCDs and DR
3. Patients with diabetes attending DR screening
Key exclusion criteriaDoes not meet inclusion criteria
Date of first enrolment15/07/2025
Date of final enrolment01/06/2026

Locations

Countries of recruitment

  • Malawi

Study participating centre

Kamuzu Universtiy of Health Sciences
52X8+782, Mahatma Gandhi Rd
Blantyre
-
Malawi

Sponsor information

London School of Hygiene & Tropical Medicine
University/education

Keppel Street
London
WC1E
England
United Kingdom

Phone +44 (0)20 7636 8636
Email RGIO@lshtm.ac.uk
Website http://www.lshtm.ac.uk/
ROR logo "ROR" https://ror.org/00a0jsq62

Funders

Funder type

Government

NIHR Global Health Policy and Systems Research Programme
Government organisation / National government
Alternative name(s)
National Institute for Health Research, NIHR Research, NIHRresearch, NIHR - National Institute for Health Research, NIHR (The National Institute for Health and Care Research), NIHR
Location
United Kingdom

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planPlanned publication in a peer-reviewed journal
IPD sharing planThe datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.
covadonga.bascaran@lshtm.ac.uk

Editorial Notes

06/06/2025: The recruitment start date was changed from 01/06/2025 to 15/07/2025.
08/04/2025: Trial's existence confirmed by the National Institute for Health and Care Research (NIHR) (UK).